Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001615774-17-001113
Filing Date
2017-03-17
Accepted
2017-03-16 21:23:43
Documents
5
Effectiveness Date
2017-03-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A s105593_defa14a.htm DEFA14A 40547
2 EX-99.1 s105593_ex1.htm EX-99.1 10107
3 GRAPHIC image_002.jpg GRAPHIC 2350
4 GRAPHIC image_003.jpg GRAPHIC 2482
5 GRAPHIC image_001.jpg GRAPHIC 5819
  Complete submission text file 0001615774-17-001113.txt   66893
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37606 | Film No.: 17696224
SIC: 8731 Services-Commercial Physical & Biological Research